Department of Biotechnology & Biomedicine, Technical University of Denmark, Kongens Lyngby, Denmark.
Division of Hematology and Transfusion Medicine, Department of Laboratory Medicine, Lund University, Lund, Sweden.
Nat Microbiol. 2024 May;9(5):1176-1188. doi: 10.1038/s41564-024-01663-4. Epub 2024 Apr 29.
Matching donor and recipient blood groups based on red blood cell (RBC) surface ABO glycans and antibodies in plasma is crucial to avoid potentially fatal reactions during transfusions. Enzymatic conversion of RBC glycans to the universal group O is an attractive solution to simplify blood logistics and prevent ABO-mismatched transfusions. The gut symbiont Akkermansia muciniphila can degrade mucin O-glycans including ABO epitopes. Here we biochemically evaluated 23 Akkermansia glycosyl hydrolases and identified exoglycosidase combinations which efficiently transformed both A and B antigens and four of their carbohydrate extensions. Enzymatic removal of canonical and extended ABO antigens on RBCs significantly improved compatibility with group O plasmas, compared to conversion of A or B antigens alone. Finally, structural analyses of two B-converting enzymes identified a previously unknown putative carbohydrate-binding module. This study demonstrates the potential utility of mucin-degrading gut bacteria as valuable sources of enzymes for production of universal blood for transfusions.
基于红细胞(RBC)表面 ABO 糖蛋白和血浆中的抗体来匹配供体和受体的血型对于避免输血过程中潜在的致命反应至关重要。将 RBC 糖蛋白酶促转化为通用的 O 组是简化血液物流和防止 ABO 不匹配输血的一种有吸引力的解决方案。肠道共生菌 Akkermansia muciniphila 可以降解包括 ABO 表位在内的粘蛋白 O-聚糖。在这里,我们对 23 种 Akkermansia 糖苷水解酶进行了生化评估,并确定了能够有效转化 A 和 B 抗原及其四个碳水化合物延伸的外糖苷酶组合。与单独转化 A 或 B 抗原相比,红细胞上典型和扩展 ABO 抗原的酶去除显著提高了与 O 组血浆的相容性。最后,对两种 B 转化酶的结构分析确定了一个以前未知的假定的碳水化合物结合模块。这项研究证明了粘液降解肠道细菌作为生产用于输血的通用血液的有价值酶源的潜在用途。